Focal Dystonia Clinical Trial
— DSSOfficial title:
Effectiveness of rTMS and Retraining in the Treatment of Focal Hand Dystonia
Verified date | October 2019 |
Source | University of Minnesota |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study is exploring a new experimental procedure in dystonia called repetitive transcranial magnetic brain stimulation (TMS) combined with rehabilitation. The purpose of the study is to determine whether repetitive TMS is effective as a treatment to reduce symptoms in dystonia as demonstrated by improved motor performance.
Status | Completed |
Enrollment | 9 |
Est. completion date | June 2015 |
Est. primary completion date | June 2015 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 75 Years |
Eligibility |
Inclusion Criteria: - Greater than 18 years of age - Symptoms of focal hand dystonia or writer's cramp Exclusion Criteria: - History of seizure or other neurologic disorder |
Country | Name | City | State |
---|---|---|---|
United States | Program in Physical Therapy, University of Minnesota | Minneapolis | Minnesota |
United States | University of Minnesota, Program in Physical Therapy | Minneapolis | Minnesota |
Lead Sponsor | Collaborator |
---|---|
University of Minnesota |
United States,
Byl NN, Nagajaran S, McKenzie AL. Effect of sensory discrimination training on structure and function in patients with focal hand dystonia: a case series. Arch Phys Med Rehabil. 2003 Oct;84(10):1505-14. — View Citation
Kimberley TJ, Borich MR, Arora S, Siebner HR. Multiple sessions of low-frequency repetitive transcranial magnetic stimulation in focal hand dystonia: clinical and physiological effects. Restor Neurol Neurosci. 2013;31(5):533-42. doi: 10.3233/RNN-120259. — View Citation
Kimberley TJ, Schmidt RL, Chen M, Dykstra DD, Buetefisch CM. Mixed effectiveness of rTMS and retraining in the treatment of focal hand dystonia. Front Hum Neurosci. 2015 Jul 9;9:385. doi: 10.3389/fnhum.2015.00385. eCollection 2015. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change From Baseline in Global Rating of Change at Posttest (Day 5) | Symptom severity was assessed using the global rating of change (GROC). For the GROC, participants were asked to identify between one to three functions most impacted by focal hand dystonia. At posttest 1 they were then asked to select a rating of perceived change that represented the level of function compared to baseline. Perceived change consisted of a ±7 point Likert scale (+7= a very great deal better, 0= no change, -7= a very great deal worse). | Baseline and Posttest | |
Secondary | Change From Baseline in Arm Dystonia Disability Scale at Posttest (Day 5) | The Arm Dystonia Disability Scale (ADDS) is a survey where participants rate task difficulty for activities such as writing, handling utensils, and buttoning on a scale of 1-4 (1 = no difficulty ,4 = not able or marked difficulty). This is a subjective assessment of impairment due to focal hand dystonia. Scores are determined using an equation: total points scored, divided by the maximum possible (23), multiplied by the quotient by 90 and subtract from 90%. Scores range from 0%-90% with higher scores indicating more function. | Baseline and Posttest | |
Secondary | Change From Baseline in Sensation at Posttest (Day 5) | Examinations included two point discrimination. Two-point discrimination threshold was completed using a Disk-Criminator™. Participants were asked to reply "one" or "two" after each presentation. Static and dynamic stimuli were presented to the index and ring fingers bilaterally, meaning it was presented as a static stimuli or it was slowly swept across the skin (dynamic). | Baseline and Posttest | |
Secondary | Change From Baseline in Cortical Silent Period at Posttest (Day 5) | Cortical silent period (CSP) testing was completed during an isometric contraction of the target muscle whereby the motor evoked potential is followed by a short duration of electromyographic quiescence. The maximal voluntary contraction for finger abduction was recorded using a custom strain gauge placed around the index finger. Real-time visual feedback was given on a laptop screen to project the force produced by the participant and 20% of the maximum of three trials was calculated and displayed on a target line. For the CSP, participants were asked to contract until the target line was met, then a single transcranial magnetic stimulation pulse was delivered to the motor cortex. Ten trials were collected with a short rest period to prevent fatigue. CSP duration was calculated in milliseconds (ms). CSP EMG data were first rectified, and then a 10-ms moving average calculation was applied to the data. The onset of the CSP was set as the time point of the delivery of the TM |
Baseline and Posttest | |
Secondary | Change From Baseline for Pressure During Hand Writing at Posttest (Day 5) | Digitized handwriting was assessed using a computerized tablet (WACOM Co., Ltd., japan) with MovAlyzeR® (Neuroscript LLC, Tempe, AZ) hardware and software. Participants used a custom modified digitized pen (Kiko Software, Netherlands) to write in a self-selected pace and style on the tablet with real-time visual feedback. Writing tasks included "My country tis of thee" at a self-selected pace, repeated eight times. Data were sampled at 215 Hz (resolution: 5080 lpi, accuracy: ±0.01 pressure range: 0-800 g). Writing samples were segmented by points of minimal velocity into single strokes for analysis. Pressure for each stroke was automatically calculated within the software. | Baseline and Posttest | |
Secondary | Change From Baseline for Physician Rated Impairment at Posttest (Day 5) | Video recordings were made as participants wrote on a pad of paper with pen. Participants were asked to draw a series of 10 loops across the pad of paper followed by "The dog is barking" and their signature, each repeated four times. A physician blinded to participant allocation rated recordings. Scoring criteria were adapted from a standardized writer's cramp rating scale (WCRS) (Wissel et al., 1996), rating pathological flexion or extension at the wrist, fingers and elbow, presence of tremor, dystonic posture, writing speed and latency of dystonic symptoms. Final scores are expressed as a rating listed as a movement score. | Baseline and Posttest | |
Secondary | Change From Baseline in Physical Function at Posttest (Day 5) | Participants completed the full SF-36 assessment with subsection of interest: "physical functioning". | Baseline and Posttest |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04692285 -
Electrophysiological and Neuroimaging Correlates of the Effect of Zolpidem in Patients With Focal Dystonia
|
Phase 1 | |
Completed |
NCT00505323 -
Motor and Premotor Cortex Stimulation for Treatment of Secondary Focal Dystonia With Striato Palliadal Lesion : Evaluation of Safety and Effectiveness
|
Phase 1 | |
Terminated |
NCT03206112 -
Loss of Depotentiation in Focal Dystonia
|
||
Completed |
NCT00025701 -
EEG and EMG Studies of Hand Dystonia
|
N/A | |
Completed |
NCT02334683 -
Compare Two Guidance Techniques for Botulinum Toxin Injections for the Treatment of Limb Spasticity and Focal Dystonia
|
N/A | |
Completed |
NCT03797638 -
Characterization of Manual Dexterity by Finger Force Manipuladum (FFM) in Patients With Writer's Cramp and in Control Subjects
|
N/A | |
Terminated |
NCT01750346 -
Acetyl Hexapeptide-8 for Blepharospasm
|
Phase 2 | |
Terminated |
NCT02106936 -
Depotentiation in People With Focal Hand Dystonia
|
N/A | |
Completed |
NCT00310414 -
fMRI Studies of Task Specificity in Focal Hand Dystonia
|
N/A | |
Completed |
NCT00309010 -
Neurophysiology of Task-Specificity of Focal Hand Dystonia
|
N/A | |
Completed |
NCT03471923 -
Non-Motor Features of Cervical Dystonia (CD)
|
||
Completed |
NCT00306865 -
Brain Changes in Patients With Focal Hand Dystonia
|
N/A | |
Completed |
NCT00411255 -
Brain Stimulation to Treat Blepharospasm or Meige Syndrome
|
Phase 2 | |
Terminated |
NCT00487383 -
Brain Changes in Blepharospasm
|
||
Recruiting |
NCT05095740 -
Effects of Neuromodulation in Laryngeal Dystonia
|
N/A | |
Completed |
NCT00713414 -
Role of Neurotransmission and Functional CNS Networks in Spasmodic Dysphonia
|
||
Completed |
NCT00942851 -
A Study of Acetyl Hexapeptide-8 (AH8) in Treatment of Blepharospasm
|
Phase 1/Phase 2 | |
Completed |
NCT00118586 -
Neuropathology of Spasmodic Dysphonia
|
||
Completed |
NCT02326818 -
Comparison of Electrophysiologic and Ultrasound Guidance for Onabotulinum Toxin A Injections in Focal Upper Extremity Dystonia and Spasticity
|
Phase 3 | |
Active, not recruiting |
NCT02911103 -
Deep Brain Stimulation Surgery for Focal Hand Dystonia
|
Phase 1/Phase 2 |